A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer’s disease ; volume:9 ; number:1 ; day:7 ; month:6 ; year:2017 ; pages:1-14 ; date:12.2017
Alzheimer's research & therapy ; 9, Heft 1 (7.6.2017), 1-14, 12.2017
- Urheber
-
Wang, Shao-Wei
- Beteiligte Personen und Organisationen
-
Liu, Dong-qun
Zhang, Ling-xiao
Ji, Mei
Zhang, Yang-xin
Dong, Quan-xiu
Liu, Shu-Ying
Xie, Xi-xiu
Liu, Rui-tian
SpringerLink (Online service)
- DOI
-
10.1186/s13195-017-0267-5
- URN
-
urn:nbn:de:1111-201710182605
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Shao-Wei
- Liu, Dong-qun
- Zhang, Ling-xiao
- Ji, Mei
- Zhang, Yang-xin
- Dong, Quan-xiu
- Liu, Shu-Ying
- Xie, Xi-xiu
- Liu, Rui-tian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline
Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies
Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies
Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
Management of oxidative stress and other pathologies in Alzheimer’s disease
Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer’s dementia
Interleukin-1 mediates Alzheimer and Lewy body pathologies
Predicting probable Alzheimer’s disease using linguistic deficits and biomarkers
Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts
Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline
Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies
Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies
Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
Management of oxidative stress and other pathologies in Alzheimer’s disease
Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer’s dementia
Interleukin-1 mediates Alzheimer and Lewy body pathologies
Predicting probable Alzheimer’s disease using linguistic deficits and biomarkers
Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts
Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline
Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies
Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies
Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
Management of oxidative stress and other pathologies in Alzheimer’s disease
Distinguishing neurocognitive deficits in adult patients with NP-C from early onset Alzheimer’s dementia
Interleukin-1 mediates Alzheimer and Lewy body pathologies
Predicting probable Alzheimer’s disease using linguistic deficits and biomarkers
Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts